How to buy Acasti Pharma stock | $1.68

Acasti Pharma Inc is a biotechnology business based in the US. Acasti Pharma shares (ACST) are listed on the NASDAQ and all prices are listed in US Dollars.

Acasti Pharma stock price (NASDAQ: ACST)

Use our graph to track the performance of ACST stocks over time.

Acasti Pharma shares at a glance

• Key figures

Information last updated 2021-10-23.

Latest market close	$1.68
52-week range	$1.44 - $9.76
50-day moving average	$2.00
200-day moving average	$3.44
Wall St. target price	$2.04
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-0.98

Buy Acasti Pharma shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Acasti Pharma stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Acasti Pharma price performance over time

Historical closes compared with the close of $1.68 from 2021-10-22

1 week (2021-10-18)	-1.75%
1 month (2021-09-22)	N/A
3 months (2021-07-26)	265.22%
6 months (2021-04-26)	217.04%

1 year (2020-10-23)	711.59%
2 years (2019-10-25)	-11.58%
3 years (2018-10-25)	55.56%
5 years (2016-10-25)	19.15%

Acasti Pharma financials

Revenue TTM	$196,000
Gross profit TTM	$120,000
Return on assets TTM	-15.11%
Return on equity TTM	-56.22%
Profit margin	0%
Book value	$2.05
Market capitalisation	$75.2 million

TTM: trailing 12 months

Shorting Acasti Pharma shares

There are currently 1.0 million Acasti Pharma shares held short by investors – that's known as Acasti Pharma's "short interest". This figure is 53.5% up from 666,452 last month.

There are a few different ways that this level of interest in shorting Acasti Pharma shares can be evaluated.

Acasti Pharma's "short interest ratio" (SIR)

Acasti Pharma's "short interest ratio" (SIR) is the quantity of Acasti Pharma shares currently shorted divided by the average quantity of Acasti Pharma shares traded daily (recently around 1.1 million). Acasti Pharma's SIR currently stands at 0.89. In other words for every 100,000 Acasti Pharma shares traded daily on the market, roughly 890 shares are currently held short.

However Acasti Pharma's short interest can also be evaluated against the total number of Acasti Pharma shares, or, against the total number of tradable Acasti Pharma shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Acasti Pharma's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Acasti Pharma shares in existence, roughly 20 shares are currently held short) or 0.0231% of the tradable shares (for every 100,000 tradable Acasti Pharma shares, roughly 23 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Acasti Pharma.

Find out more about how you can short Acasti Pharma stock.

Acasti Pharma share dividends

We're not expecting Acasti Pharma to pay a dividend over the next 12 months.

Have Acasti Pharma's shares ever split?

Acasti Pharma's shares were split on a 1:8 basis on 30 August 2021. So if you had owned 8 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Acasti Pharma shares – just the quantity. However, indirectly, the new 700% higher share price could have impacted the market appetite for Acasti Pharma shares which in turn could have impacted Acasti Pharma's share price.

Acasti Pharma share price volatility

Over the last 12 months, Acasti Pharma's shares have ranged in value from as little as $1.44 up to $9.76. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Acasti Pharma's is 1.5059. This would suggest that Acasti Pharma's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Acasti Pharma overview

Acasti Pharma Inc. , a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre, an omega-3 phospholipid therapeutic to treat patients with hypertriglyceridemia. The company was incorporated in 2002 and is headquartered in Laval, Canada. .

Frequently asked questions

What percentage of Acasti Pharma is owned by insiders or institutions?
Currently 12.086% of Acasti Pharma shares are held by insiders and 0.937% by institutions. When does the fiscal year end for Acasti Pharma?
Acasti Pharma's fiscal year ends in March. Where is Acasti Pharma based?
Acasti Pharma's address is: 3009 boulevard de la Concorde East, Laval, QC, Canada, H7E 2B5 What is Acasti Pharma's ISIN number?
Acasti Pharma's international securities identification number is: CA00430K4028 What is Acasti Pharma's CUSIP number?
Acasti Pharma's Committee on Uniform Securities Identification Procedures number is: 00430K105